Attitudes of women towards products containing hormones (hormonal contraceptives or hormone therapy): what changes from pre to postmenopause?

Abstract

Facchinetti (2021) Attitudes of women towards products containing hormones (hormonal contraceptives or hormone therapy): what changes from pre to postmenopause?,

Perception about benefits and risks related to combined hormonal contraceptives use in women with Lynch syndrome

“…In our study, both healthy women and those with LS showed a wrongly negative perception related to the use of CHCs and the risk of developing endometrial cancer. These results confirmed the lack of awareness about the benefit of using CHCs on preventing endometrial cancer reported also in the general population by a previous study [ 12 ]. However, women with LS had a significantly more negative opinion on this matter compared to the control group.…”

“…Nevertheless, in daily practice, myths and taboos regarding side effects and long-term consequences of CHC use on women’s health need to be fully addressed also in the general population [ 12 ]. The awareness of the effects of hormonal therapies in women at high risk of developing endometrial cancer, colorectal, or ovarian cancer, such as those affected by LS, is even more limited, with few published studies addressing the perception about benefits and risks related to CHCs only in BRCA pathogenic variant carriers [ 13 , 14 ].…”

Contraception During Perimenopause: Practical Guidance

“…Moreover, the age-related issues associated with the use of hormonal therapies must be analysed. 12 Importantly, among them is the increased risk of cancer, the possible occurrence of osteopenia and osteoporosis, the risk of thromboembolism, psychological changes and the possible sexual dysfunction associated with this peculiar late reproductive period. 13 Regarding the thromboembolic risk, it is strictly related to hypertension and cardiovascular diseases in general, as well as obesity and metabolic syndrome, whose incidence rises with age.…”